Amneal Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Description of Registrants Securities (Filed With SEC on March 2, 2020)
- Form of Tripartite Acknowledgment and Agreement Morgan Stanley (Filed With SEC on August 5, 2019)
- Commitment Letter, dated as of October 17, 2017, among JPMorgan Chase Bank, Bank of America, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Amneal Pharmaceuticals LLC (Filed With SEC on May 7, 2018)
- PIPE Side Letter, dated November 21, 2017, by and among Amneal Holdings, LLC, Atlas Holdings, Inc., and TPG Improv Holdings, L.P (Filed With SEC on May 7, 2018)
- Letter Agreement, dated as of June 26, 2015, between RBC Capital Markets LLC and Impax regarding the Additional Call Option Transaction (Filed With SEC on April 13, 2018)
- Letter Agreement, dated as of June 26, 2015, between RBC Capital Markets LLC and Impax regarding the Additional Warrants (Filed With SEC on April 13, 2018)
- Letter Agreement, dated as of June 25, 2015, between RBC Capital Markets LLC and Impax regarding the Base Call Option Transaction (Filed With SEC on April 13, 2018)
- Letter Agreement, dated as of June 25, 2015, between RBC Capital Markets LLC and Impax regarding the Base Warrants (Filed With SEC on April 13, 2018)
- Tax Receivable Agreement, among Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and the Members of Amneal Pharmaceuticals LLC from time to time party thereto (Filed With SEC on April 13, 2018)
- Commitment Letter, dated as of October 17, 2017, among JPMorgan Chase Bank, Bank of America, N.A., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Amneal Pharmaceuticals LLC (Filed With SEC on April 13, 2018)
- PIPE Side Letter, dated November 21, 2017, by and among Amneal Holdings, LLC, Atlas Holdings, Inc., and TPG Improv Holdings, L.P (Filed With SEC on April 13, 2018)
